Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Natural History Characterization in Symptomatic and Asymptomatic Progranuline Gene Mutation Carriers

NCT04014673

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations: Groupe Hospitalier Pitié-Salpêtrière - Charles Foix Paris, France

Pitié Salpetriere Hospital Paris, France

View Trial Details

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis

NCT05981040

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Zydus Hospitals & Healthcare Research Ahmedabad, Gujarat, India

Rhythm heart institute Vadodara, Gujarat, India

BrainS Super Speciality Hospital Bengaluru, Karnataka, India

KIMS-Kingsway Hospitals Nagpur, Maharashtra, India

View Trial Details

Completed

Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases

NCT02532244

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Charcot-Marie-Tooth Disease, +28 more
Locations: Nemours Children's Hospital Delaware Wilmington, Delaware, United States

Nemours Children's Specialty Care Jacksonville, Florida, United States

Nemours Children's Hospital Orlando Orlando, Florida, United States

View Trial Details

Completed

Long-term Effect of TMS in Primary Progressive Aphasia

NCT05842473

Conditions: Alzheimer Disease, Aphasia, Aphasia, Primary Progressive, +22 more
Locations: Hospital Clínico San Carlos. Madrid, Spain

View Trial Details

Completed

Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration

NCT02964611

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +18 more
Locations: Toronto Western Hospital, University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

Geometrical Facial Deformation According to Posture in Amyotrophic Lateral Sclerosis

NCT04798183

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Pusan National University Yangsan Hospital Yangsan, Gyeongsangnam-do, South Korea

View Trial Details

Completed

Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)

NCT05276349

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

Emory University Atlanta, Georgia, United States

View Trial Details

Completed

Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial

NCT04489017

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations: Giacomo Koch Rome, Italy

Santa Lucia Foundation Rome, Italy

View Trial Details

Completed

Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS

NCT06676423

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Hanyang university hospital Seoul, South Korea

View Trial Details

Completed

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients

NCT05407428

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Sourasky medical center Tel Aviv, Israel

View Trial Details

TDP-43 Proteinopathies

TDP-43 Proteinopathies trial results

Related conditions